Compare Novartis AG (NVS) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Wayfair Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Wayfair Inc trades at $84.8 (market cap $11.58B). The key difference: Novartis AG is far larger — about 25.1× Wayfair Inc's market cap, and Novartis AG pays a 3.17% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals.
| NVS | W | |
|---|---|---|
Market Cap | $290.25B | $11.58B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $119.05 |
52-Week Low | $113.50 | $56.42 |
Enterprise Value | $330.27B | $14.16B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
